COVID-19

Evaluating the feasibility of telemedicine in movement disorders care 1:56
Evaluating the feasibility of telemedicine in movement disorders care
Esther Cubo • 15 Sep 2022
COVID-19 and post-acute neurological sequelae 4:12
COVID-19 and post-acute neurological sequelae
Jennifer Frontera • 3 Apr 2022
Updates on peripheral autoimmune neurological conditions 2:44
Updates on peripheral autoimmune neurological conditions
Divyanshu Dubey • 12 Apr 2022
Efforts to expedite progress in neurology after the COVID-19 pandemic 1:11
Efforts to expedite progress in neurology after the COVID-19 pandemic
Nina Schor • 4 Apr 2022
Evaluating the long-term cognitive effects of COVID-19 3:56
Evaluating the long-term cognitive effects of COVID-19
Jennifer Frontera • 3 Apr 2022
Prognostic and predictive biomarkers for long COVID 2:26
Prognostic and predictive biomarkers for long COVID
Jennifer Frontera • 3 Apr 2022
Benefits of remote rehabilitation programmes for patients with MS 1:51
Benefits of remote rehabilitation programmes for patients with MS
Letizia Leocani • 4 Apr 2022
An analysis of COVID-19 infection and vaccinations in epilepsy patients 1:04
An analysis of COVID-19 infection and vaccinations in epilepsy patients
Bernhard Steinhoff • 27 Jun 2022
Disentangling the concept of post-acute COVID-19 sequalae 6:04
Disentangling the concept of post-acute COVID-19 sequalae
Jennifer Frontera • 3 Apr 2022
An update on neurological adverse events from COVID-19 vaccines 3:46
An update on neurological adverse events from COVID-19 vaccines
Jennifer Frontera • 3 Apr 2022
Emergence of CBT as first-line treatment for insomnia 1:13
Emergence of CBT as first-line treatment for insomnia
Michelle Jonelis • 23 Mar 2022
Changes in the MS treatment landscape over the last 2 years 6:03
Changes in the MS treatment landscape over the last 2 years
Abhijit Chaudhuri • 22 Mar 2022
The impact of COVID-19 on palliative care in Parkinson’s disease 2:49
The impact of COVID-19 on palliative care in Parkinson’s disease
Angelo Antonini • 29 Mar 2022
The emergence of COVID-19-induced parkinsonism 2:48
The emergence of COVID-19-induced parkinsonism
Angelo Antonini • 29 Mar 2022
Increasing mobility in patients with Parkinson’s disease during COVID-19 2:58
Increasing mobility in patients with Parkinson’s disease during COVID-19
Angelo Antonini • 29 Mar 2022
The importance of studying long-term COVID-19 neurological symptoms 2:12
The importance of studying long-term COVID-19 neurological symptoms
Giulio Pasinetti • 18 Mar 2022
The content of VJNeurology is intended for healthcare professionals